Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Bozzetti

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Age (Dordrecht, Netherlands)|September 2, 2015
Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cellsUlrik Stervbo, Sarah Meier, Julia Nora Mälzer, et al.
Diagnostic Cytopathology|July 9, 2015
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patientsCecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, et al.
Oncology Reports|October 4, 2019
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancerFrancesca Negri, Cecilia Bozzetti, Giuseppe Pedrazzi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancerMarcello Tiseo, Marzia Capelletti, Giuseppe De Palma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancerMaura Loprevite, Marcello Tiseo, Maurizio Chiaramondia, et al.
Frontiers in Oncology|March 17, 2023
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, et al.
Future Oncology (London, England)|November 10, 2015
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancerFrancesca V Negri, Pellegrino Crafa, Giuseppe Pedrazzi, et al.
Plos One|November 17, 2015
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture MethodCecilia Bozzetti, Federico Quaini, Anna Squadrilli, et al.
Hemasphere|February 26, 2026
Intra-subtype heterogeneity shapes treatment response in <i>KMT2A</i>-rearranged ALL across all age groupsAlina M Hartmann, Lorenz Bastian, Malwine J Barz, et al.
Blood|March 13, 2026
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple MyelomaJohanna M Horns, Thomas Beder, Axel Künstner, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Age (Dordrecht, Netherlands)|September 2, 2015
Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cellsUlrik Stervbo, Sarah Meier, Julia Nora Mälzer, et al.
Diagnostic Cytopathology|July 9, 2015
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patientsCecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, et al.
Oncology Reports|October 4, 2019
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancerFrancesca Negri, Cecilia Bozzetti, Giuseppe Pedrazzi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancerMarcello Tiseo, Marzia Capelletti, Giuseppe De Palma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancerMaura Loprevite, Marcello Tiseo, Maurizio Chiaramondia, et al.
Frontiers in Oncology|March 17, 2023
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, et al.
Future Oncology (London, England)|November 10, 2015
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancerFrancesca V Negri, Pellegrino Crafa, Giuseppe Pedrazzi, et al.
Plos One|November 17, 2015
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture MethodCecilia Bozzetti, Federico Quaini, Anna Squadrilli, et al.
Hemasphere|February 26, 2026
Intra-subtype heterogeneity shapes treatment response in <i>KMT2A</i>-rearranged ALL across all age groupsAlina M Hartmann, Lorenz Bastian, Malwine J Barz, et al.
Blood|March 13, 2026
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple MyelomaJohanna M Horns, Thomas Beder, Axel Künstner, et al.
Pageof 3